Lung Cancer Nursing UK
Support professional development of lung cancer/mesothelioma nurse specialists,provide a voice for lung cancer/mesothelioma nurse specialists on clinical and strategic issues & service delivery,support the development of research, audit & the knowledge base of lung cancer/mesothelioma research,audit & service delivery, contribute to the development of tools & resources for patients and carers
Financial health, per its FY2025 accounts
The accounts state that the charity ended the year with an operating surplus of £75,193 and held unrestricted reserves of £403,768. The trustees report that these reserves meet the optimum level of maximum reserves, which is defined as twelve months of fixed operating costs plus the annual cost of the conference. While the charity faces challenges regarding rising costs and funding uncertainty, it maintains a healthy financial position with no material uncertainties affecting its going concern status.
What the accounts disclose
Trustees
- Catherine Haywood
- Dominic Celestine Smith
- Lorraine Creech
- Nicola Alexandra Handley
- Professor David Baldwin
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/01/2025 | £233k | £158k |
| 31/01/2024 | £164k | £156k |
| 31/01/2023 | £197k | £147k |
| 31/01/2022 | £118k | £103k |
| 31/01/2021 | £33k | £51k |
Common questions
Is Lung Cancer Nursing UK financially healthy?
Per its FY2025 accounts: The accounts state that the charity ended the year with an operating surplus of £75,193 and held unrestricted reserves of £403,768. The trustees report that these reserves meet the optimum level of maximum reserves, which is defined as twelve months of fixed operating costs plus the annual cost of the conference. While the charity faces challenges regarding rising costs and funding uncertainty, it maintains a healthy financial position with no material uncertainties affecting its going concern status. Its FY2025 accounts were independently examined.